Drug Shortage Report for DEXTROSE INJECTION
| Report ID | 201190 |
| Drug Identification Number | 02517132 |
| Brand name | DEXTROSE INJECTION |
| Common or Proper name | Dextrose Injection |
| Company Name | OMEGA LABORATORIES LIMITED |
| Market Status | MARKETED |
| Active Ingredient(s) | DEXTROSE |
| Strength(s) | 50% |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS |
| Packaging size | 10 x 50mL vial / fiole |
| ATC code | B05BA |
| ATC description | I.V. SOLUTIONS |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | |
| Actual start date | 2023-08-07 |
| Estimated end date | 2024-05-01 |
| Actual end date | 2024-03-21 |
| Shortage status | Resolved |
| Updated date | 2024-03-22 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | Yes |
| Contact Address | 11177 HAMON MONTREAL, QUEBEC CANADA H3M 3E4 |
| Company contact information | [email protected] - 1-800-363-0584 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.